Freedom Capital Markets downgrades Nebius stock rating on valuation concerns

Freedom Capital Markets downgraded Nebius Group to Hold from Buy but lifted its price target to $154 from $108, citing the stock’s rapid 70% rise since Feb. 2 to $144.97 and near-52-week-high valuation. The firm raised 2026 and 2027 revenue and adjusted EBITDA estimates, with growth expected to accelerate 209% and 336% from 2026 to 2027, respectively. Nebius also announced a $4 billion convertible notes offering and a 310 MW AI factory buildout in Finland, while other analysts remained constructive with targets of $150 and $200 tied to a Meta contract worth $12 billion, potentially rising by $15 billion.

Analysis

NBIS is transitioning from a momentum story to a financing-and-execution story, which changes the tradeable setup. The near-term issue is not demand, it is whether the market starts to price the dilution and duration mismatch created by funding multi-year capex with a large convertible stack while the revenue step-up is still back-half weighted. That typically creates a window where the equity can de-rate even as fundamental estimates rise, especially after a vertical run.

The second-order winner here is META, but mostly as a bargaining-counterparty, not as a clean earnings winner yet. If NBIS has credible incremental capacity and large AI customers keep signing multi-year supply deals, hyperscalers and frontier model labs gain a diversified source of compute, which reduces single-vendor dependency and could pressure pricing at the margin across AI infrastructure providers. The losers are smaller colocators and “AI capacity” names without balance-sheet scale; investors may increasingly discriminate between contracted megawatt pipelines and promotional growth stories.

The key catalyst/risk window is the next 1-3 months, when the market has to absorb the convert terms, equity overhang, and any follow-on disclosure around contract economics. If the stock fails to hold above the recent breakout zone after the financing settles, the setup could unwind quickly because the incremental buyers are already in. Conversely, if customers validate the utilization ramp and the market starts underappreciating 2027 EBITDA, the stock can remain expensive longer than expected, but that requires flawless execution into a very high bar.

The contrarian view is that consensus may be over-fixated on the headline multiple expansion while underestimating how little near-term free cash flow this model can generate once capex and interest are layered in. That makes NBIS vulnerable to any disappointment in deployment timing, power availability, or customer conversion from contract to billing. In that sense, the upside is real but increasingly crowded, while the downside is driven by financing optics and execution slippage rather than demand collapse.

Key Decisions for Investors

• Trim or fade NBIS on strength into the next 2-4 weeks; the risk/reward is unfavorable after the run unless there is a pullback to a post-convert support level where valuation resets and dilution is digested.
• Consider a NBIS put spread 1-3 months out to express a view that financing overhang and execution risk will compress the multiple even if estimates continue to rise; use a defined-risk structure because momentum can persist.
• Long META vs short a basket of smaller AI infrastructure/colocation names over 1-3 months; META benefits from optionality and bargaining power while weaker peers face capital intensity and customer concentration risk.
• If already long NBIS, hedge with short-dated puts or a partial collar through the next funding/operational update; this protects against a sharp de-rating if the market decides the convert and capex dilute nearer-term equity value.
• For longer-term accounts, wait for evidence of capacity monetization before adding; the cleaner entry is after initial deployment milestones, when the market can verify that contracted MW turns into cash flow rather than just backlog.